Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB. Trevisan, Francesca Fulvia Pepe, I. Vallini et al.|Scientific Reports|2023Cited by 5
Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancerPierFranco Conte, Valentina Guarneri, A.A. Brandes et al.|Annals of Oncology|2017Cited by 4